[Elsevier] An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study

myyoyolin Post time 2024-6-17 17:30:19 | Show all posts |Read mode
Reward10points

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02037-2/abstract

Thanks!

Best Answer

Reply

Use magic Donate Report

All Reply2 Show all posts
Drmahmoudshaban Post time 2024-6-17 17:30:20 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Drmahmoudshaban Post time 2024-6-17 17:34:05 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    930

Latest Reply

Return to the list